In 2011, what approach to drug policies did the Global Commission on Drug Policy endorse?

The Global Commission on Drug Policy, established in 2011, advocated for a harm reduction approach to drug policies. This perspective emphasizes minimizing the negative consequences associated with drug use rather than solely focusing on reducing the use of drugs themselves. Harm reduction strategies prioritize public health and social responsibility, promoting safer use, treatment options, and supportive measures for individuals affected by drug-related issues.

The harm reduction model recognizes that drug use can be a complex societal issue and addresses it through pragmatic approaches, such as providing access to clean syringes, safe consumption spaces, and overdose prevention strategies. This approach contrasts with punitive measures, which can exacerbate public health problems and lead to increased stigma and marginalization of drug users. Therefore, the endorsement of harm reduction reflects a shift toward more compassionate and effective policies that consider the well-being of individuals and communities.